DrugPatentWatch Database Preview
BRIDION Drug Profile
Which patents cover Bridion, and when can generic versions of Bridion launch?
Bridion is a drug marketed by Organon Sub Merck and is included in one NDA. There are three patents protecting this drug.
This drug has fifty-five patent family members in thirty countries.
The generic ingredient in BRIDION is sugammadex sodium. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sugammadex sodium profile page.
Summary for BRIDION
| International Patents: | 55 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 12 |
| Clinical Trials: | 45 |
| Patent Applications: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for BRIDION |
| DailyMed Link: | BRIDION at DailyMed |
Generic Entry Opportunity Date for BRIDION
Generic Entry Date for BRIDION*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
SOLUTION;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for BRIDION
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of South Florida | Phase 3 |
| Yonsei University | N/A |
| McGill University Health Center | N/A |
Pharmacology for BRIDION
Synonyms for BRIDION
| 1202253-72-2 |
| 343306-71-8 |
| 343306-79-6 |
| 361LPM2T56 |
| 862667-16-1 |
| AC-30384 |
| Bridion (TN) |
| CHEBI:90952 |
| CHEBI:90953 |
| D05940 |
| DB06206 |
| ERJ6X2MXV7 |
| EX-A2600 |
| gamma-Cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-octathio-, octasodium salt |
| MK-8616 |
| Octasodium 6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octakis-S-(2-carboxylatoethyl)-6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octathiocyclo-alpha-(1-4)-D-octaglucopyranoside |
| Org 25969 |
| ORG-25969 |
| SCH-900616 |
| SCHEMBL13917069 |
| Sugammadex |
| Sugammadex [USAN:INN:BAN] |
| Sugammadex Sodium |
| Sugammadex sodium (JAN/USAN) |
| Sugammadex sodium [USAN:JAN] |
| UNII-361LPM2T56 |
| UNII-ERJ6X2MXV7 |
US Patents and Regulatory Information for BRIDION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | RX | Yes | No | See Pricing | See Pricing | Y | Y | See Pricing | ||
| Organon Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-001 | Dec 15, 2015 | RX | Yes | Yes | See Pricing | See Pricing | Y | Y | See Pricing | ||
| Organon Sub Merck | BRIDION | sugammadex sodium | SOLUTION;INTRAVENOUS | 022225-002 | Dec 15, 2015 | RX | Yes | No | See Pricing | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for BRIDION
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2003515623 | See Pricing |
| China | 1370073 | See Pricing |
| Australia | 5438001 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for BRIDION
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1259550 | 300356 | Netherlands | See Pricing | |
| 1259550 | 47/2008 | Austria | See Pricing | PRODUCT NAME: SUGAMMADEX; 6-PER-DEOXY-6-PER-(2-CARBOXYETHYL) THIO-Y-CYCLODEXTRIN UND PHARMAZEUTISCH VERTRAEGLICHES SALZ HIERVON; REGISTRATION NO/DATE: EU/1/08/466/001-002 20080725 |
| 1259550 | SPC031/2008 | Ireland | See Pricing | SPC031/2008: 20090428, EXPIRES: 20230724 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
